Ibuprofen could reduce cardioprotective effect of aspirin

February 13, 2003

A research letter in this week's issue of THE LANCET suggests that the painkiller ibuprofen could diminish the well-known beneficial effects of aspirin on preventing cardiovascular disease.

Aspirin makes platelets (blood-clotting cells) less 'sticky', which is associated with fewer thromboses (clots). Aspirin therefore reduces the chance of heart attacks caused by coronary thrombosis and stroke (cerebral thrombosis). Previous laboratory research has suggested that ibuprofen interacts with aspirin to reduce this 'good' effect of aspirin on platelet stickiness.

Tom MacDonald and Li Wei from the Medicines Monitoring Unit (MEMO) at the University of Dundee, Ninewells Hospital& Medical School, UK, studied 7107 patients with cardiovascular disease who were discharged from hospital and who were taking prescribed low-dose aspirin. Within this group they compared the death rate (from any cause and from cardiovascular causes) of those patients taking prescribed aspirin alone with those taking prescribed aspirin and ibuprofen. They also compared mortality data for patients taking another common painkiller (diclofenac) and those taking any of the other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in addition to aspirin.

Individuals prescribed both aspirin and ibuprofen (187 patients) had about a doubling of risk of death from any cause and around a 75% increased risk of death from cardiovascular disease, compared with those prescribed aspirin alone. There was no increase in mortality risk for people prescribed aspirin in combination with diclofenac or other NSAIDs.

Tom MacDonald comments: "Although our findings are not conclusive, they do support the hypothesis that ibuprofen may reduce the benefits of aspirin in people with cardiovascular disease. Perhaps it would be prudent that such patients took an alternative painkiller at least until this issue is further clarified. Furthermore, we also know that aspirin and ibuprofen taken together increases the risk of bleeding from stomach ulcers. So this combination may not only reduce the benefits of aspirin, but may also increase the risks of side effects."
-end-
Contact: Professor Tom MacDonald, Medicines Monitoring Unit, Department of Clinical Pharmacology and Therapeutics, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK;
T) 44-138-263-2575;
F) 44-138-264-2637;
E) macdonaldtom@memo.dundee.ac.uk

Lancet

Related Cardiovascular Disease Articles from Brightsurf:

Changes by income level in cardiovascular disease in US
Researchers examined changes in how common cardiovascular disease was in the highest-income earners compared with the rest of the population in the United States between 1999 and 2016.

Fighting cardiovascular disease with acne drug
Researchers from the European Molecular Biology Laboratory (EMBL) in Heidelberg and Stanford University have found the cause of dilated cardiomyopathy - a leading cause of heart failure - and identified a potential treatment for it: a drug already used to treat acne.

A talk with your GP may prevent cardiovascular disease
Having a general practitioner (GP) who is trained in motivational interviewing may reduce your risk of getting cardiovascular disease.

Dilemma of COVID-19, aging and cardiovascular disease
Whether individuals should continue to take angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the context of coronavirus disease 2019 (COVID-19) is discussed in this article.

Air pollution linked to dementia and cardiovascular disease
People continuously exposed to air pollution are at increased risk of dementia, especially if they also suffer from cardiovascular diseases, according to a study at Karolinska Institutet in Sweden published in the journal JAMA Neurology.

New insights into the effect of aging on cardiovascular disease
Aging adults are more likely to have - and die from - cardiovascular disease than their younger counterparts.

Premature death from cardiovascular disease
National data were used to examine changes from 2000 to 2015 in premature death (ages 25 to 64) from cardiovascular disease in the United States.

Ultrasound: The potential power for cardiovascular disease therapy
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 2, pp.

Despite the ACA, millions of Americans with cardiovascular disease still can't get care
Cardiovascular disease (CVD) is the leading cause of death for Americans, yet millions with CVD or cardiovascular risk factors (CVRF) still can't access the care they need, even years after the implementation of the Affordable Care Act (ACA).

Excess weight and body fat cause cardiovascular disease
In the first Mendelian randomization study to look at this, researchers have found evidence that excess weight and body fat cause a range of heart and blood vessel diseases (rather than just being associated with it).

Read More: Cardiovascular Disease News and Cardiovascular Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.